Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Van Bael & Bellis ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
No Patentability For Products Of Essentially Biological Processes
Following this decision, the European Parliament asked the Commission in December 2015 to look into the patentability of these products.
European Union
13 Feb 2017
2
Supreme Court Acknowledges Objective Justification For Parallel Importation Of Pharmaceuticals
The Supreme Court recently handed down two judgments on the repackaging of parallel imported pharmaceuticals.
Belgium
9 Feb 2017
3
Minister For Social Affairs And Public Health Concludes "Pact For Future" With Pharmaceutical Industry
On 27 July 2015, the Minister for Social Affairs and Public Health, Maggie De Block ("the Minister"), and the pharmaceutical sector umbrella organisations pharma.be and FeBelGen entered into a "Pact for the Future"...
Belgium
21 Aug 2015
4
ECJ Clarifies Concept Of "Human Embryo" Within Meaning Of Biotech Directive
In the facts underlying the case at hand, ISCC sought to register two UK patents relating to unfertilized human ova which have been stimulated to divide in the absence of sperm.
European Union
5 Feb 2015
5
Commission Fines Servier And 5 Other Generic Producers A Total Of € 427 Million Over "Pay-For-Delay" Deals And Abuse Of A Dominant Position
Perindopril is a blood pressure control medicine that used to be Servier’s bestselling medicine.
European Union
21 Aug 2014
6
Commission Sends Statement Of Objections To Lundbeck, Servier And Others Over "Pay-For-Delay" Agreements; Third Patent Settlement Monitoring Report Published
On 25 July 2012, the European Commission announced that it had sent a formal Statement of Objections ("SO") to Danish pharmaceutical company Lundbeck over its conclusion of so-called "pay-for-delay" agreements with four generic producers of citalopram, a antidepressant medicine.
European Union
8 Aug 2012
7
ECJ Clarifies Scope Of Supplementary Protection Certificate
On 9 February 2012, the Court of Justice of the European Union (the "ECJ") answered a preliminary question referred to it by the High Court of Justice of England and Wales (the "Referring Court") in Novartis AG ("Novartis") v. Actavis UK Ltd.
European Union
11 Apr 2012
8
GMOs: A Principle Established With…Precaution
In the midst of the debate over the co-existence of traditional and GM crops, the Court of Justice of the European Union (ECJ) has delivered two very important judgments in the space of a few days.
European Union
4 Oct 2011
9
ECJ Again Rules In Favour Of Repackaging Of Parallel-Traded Pharmaceuticals
On 28 July 2011, the Court of Justice of the European Union (the "ECJ") handed down a judgment addressing questions referred to it by the Danish Supreme Court (the "Referring Court") with respect to the rules governing the repackaging of parallel-traded pharmaceuticals.
European Union
21 Sep 2011
Links to Result pages
 
1